Akron’s innovative design can help improve your cell & gene therapy manufacturing process
Expect more out of your pDNA service provider. At Akron Bio, we manufacture a robust product with high yields and unmatched purity.
Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.
Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.
Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.
At Akron, we manufacture high-quality compliant cGMP plasmid DNA for pre-clinical, clinical, and commercial gene therapy and vaccine companies where material needs are 1+ grams.
At this year's CAR-TCR Summit, Akron Bio's Vice President of Product Development and Planning, Ezequiel Zylberberg, will be discussing Key Considerations in the Assessment and Integration of cGMP-Compliant Ancillary Materials. Register today!
Akron Bio is exhibiting at this year's Cell & Gene Therapy Manufacturing & Commercialization US in Boston. Stop by Booth #129 to meet our experienced team!
Akron Bio is proud to be a Silver Level Sponsor at this year's Cell & Gene Meeting on the Mesa.
We are so excited to be a Silver level sponsor at this year's BioFlorida Annual Conference. Register today and join us in Miami, FL.
Apr 14, 2022
Akron BioProducts Announces Launch of its Closed System Solutions™ line to Enable Seamless Integration of cGMP Ancillary Materials in Cell and Gene Therapy Manufacturing
Apr 12, 2022
Akron Bio Expands Commercialization of Advanced Gene Therapy and Vaccine Production with New Manufacturing Facility
Mar 23, 2022
Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases